MetaCap

Alumis Statistics

NASDAQ: ALMSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.96-0.37 (-8.55%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Alumis by the numbers

Alumis has a market capitalization of $514.1 million based on 129.82M shares outstanding. With trailing EPS of $-3.53, Alumis is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 40.8% below its 50-day average and 80.1% below its 200-day average.

Average daily trading volume is 2.87M shares, or about $11.4 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ALMS valuation vs. peer median

ALMS compared with the median of 8 peer companies
MetricALMSPeer medianDifference
Market cap$514.09M$541.51M-5%
Avg. volume2.87M1.37M+109%

Peer median across 8 companies: ZVRA, WVE, CLYM, HELP, CBIO, AVBP, ACRS, ANL.

Valuation

Market cap
$514.09M
Price / sales (latest FY)
21.38
EPS (TTM)
$-3.53

Price and trading

Previous close
4.33
Open
4.24
Day range
3.94 – 4.36
52-week range
3.94 – 31.35
52-week change
-45.75%
Beta
—
Volume
1.79M

Dividends and events

Annual dividend
None
Next earnings date
Nov 12, 2026

Additional statistics

Market Cap
514.09M
Forward Pe
-1.36
Eps
-3.53
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
31.35
Week52 Low
3.94
Avg Volume
2.87M
Shares Outstanding
129.82M
Ma50
6.69
Ma200
19.90
Earnings Date
Nov 12, 2026
Pct From52w High
-87.37%
Pct From52w Low
0.64%

Related